Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals

Advances in Protein Chemistry and Structural Biology

Volumn 108, Issue , 2017, Pages 33-57

  Sawikr, Yousef ^a   Yarla, Nagendra Sastry ^b   Peluso, Ilaria ^c   Kamal, Mohammad Amjad ^d,e   Aliev, Gjumrakch ^f,g,h   Bishayee, Anupam ⁱ  

^a UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

^b GITAM UNIVERSITY   (India)

^c Research Center on Agriculture and Economics   (Italy)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e Global Community Educational Foundation   (Australia)

^f GALLY International Biomedical Research Institute Inc   (United States)

^g University of Atlanta   (United States)

^h INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

ⁱ Larkin Health Science Institute   (United States)

Author keywords

Advanced glycation end products; Arachidonic acid pathway; Astrogliosis; Central nervous system; Cytokines; Flavonoids; Inflammation; Reactive oxygen species

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; CURCUMIN; CYCLOOXYGENASE 2; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MULTIDRUG RESISTANCE PROTEIN; NUTRACEUTICAL; PIPERINE; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SATURATED FATTY ACID; ADVANCED GLYCATION END PRODUCT; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CYTOKINE; PLANT MEDICINAL PRODUCT; POLYPHENOL;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; COGNITION; CYTOKINE PRODUCTION; DRUG MECHANISM; GLIA CELL; GLYCOSYLATION; HUMAN; MICROGLIA; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; OXIDATIVE STRESS; SYNAPSE; ANALYSIS; ANIMAL; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACID; ASTROCYTES; CYTOKINES; DIETARY SUPPLEMENTS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; MICROGLIA; PHYTOCHEMICALS; POLYPHENOLS;

EID: 85015817471     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apcsb.2017.02.001     Document Type: Chapter

References (168)

1. Abuznait, A.H., Kaddoumi, A., Role of ABC transporters in the pathogenesis of Alzheimer's disease. ACS Chemical Neuroscience 3 (2012), 820–831.
2. Adami, C., Bianchi, R., Pula, G., Donato, R., S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochimica et Biophysica Acta 1742 (2004), 169–177.
3. Agostinho, P., Cunha, R.A., Oliveira, C., Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Current Pharmaceutical Design 16 (2010), 2766–2778.
4. Altunoglu, E., Guntas, G., Erdenen, F., Akkaya, E., Topac, I., Irmak, H., et al. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease. Geriatric and Gerontology International 15 (2015), 872–880.
5. Arab, H., Mahjoub, S., Hajian-Tilaki, K., Moghadasi, M., The effect of green tea consumption on oxidative stress markers and cognitive function in patients with Alzheimer's disease: A prospective intervention study. Caspian Journal of Internal Medicine 7 (2016), 188–194.
6. Ataie, A., Shadifar, M., Ataee, R., Polyphenolic antioxidants and neuronal regeneration. Basic and Clinical Neuroscience 7:2 (2016), 81–90.
7. Axelsson, M., Malmeström, C., Nilsson, S., Glial fibrillary acidic protein: A potential biomarker for progression in multiple sclerosis. Journal of Neurology 258 (2011), 882–888.
8. Barona, J., Blesso, C.N., Andersen, C.J., Park, Y., Lee, J., Fernandez, M.L., Grape consumption increases anti-inflammatory markers and upregulates peripheral nitric oxide synthase in the absence of dyslipidemias in men with metabolic syndrome. Nutrients 4 (2012), 1945–1957.
9. Barreto, G.E., Gonzalez, J., Cardiológicas, I.D.I., Taquini, P.A., Role of astrocytes in neurodegenerative diseases. 570 pages Chang, R.C.-C., (eds.) Neurodegenerative diseases—Processes, prevention, protection and monitoring, 2008, 258–272 InTech. ISBN 978-953-307-485-6, http://dx.doi.org/10.5772/1252. http://www.intechopen.com/books/neurodegenerative-diseases-processes-prevention-protection-and-monitoring.
10. Begum, A.N., Jones, M.R., Lim, G.P., Morihara, T., Kim, P., Heath, D.D., et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. The Journal of Pharmacology and Experimental Therapeutics 326:1 (2008), 196–208, 10.1124/jpet.108.137455.
11. Belkhelfa, M., Rafa, H., Medjeber, O., Arroul-Lammali, A., Behairi, N., Abada-Bendib, M., et al. IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: A study in Algerian patients. Journal of Interferon & Cytokine Research 34 (2014), 839–847.
12. Biesalski, H.K., Polyphenols and inflammation: Basic interactions. Current Opinion in Clinical Nutrition & Metabolic Care 10 (2007), 724–728.
13. Bogdanski, P., Suliburska, J., Szulinska, M., Stepien, M., Pupek-Musialik, D., Jablecka, A., Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutrition Research 32 (2012), 421–427.
14. Bortolotto, V., Grilli, M., Every cloud has a silver lining: Proneurogenic effects of Aβ oligomers and HMGB-1 via activation of the RAGE-NF-κB axis. CNS & Neurological Disorders Drug Targets 15 (2016), 1–14 ISSN 1871-5273/1996-3181. http://dx.doi.org/10.2174/1871527315666160803153459.
15. Braak, H., Braak, E., Strothjohann, M., Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neuroscience Letters 171 (1994), 1–4.
16. Cairns, N.J., Chadwick, A., Luthert, P.J., Lantos, P.L., Astrocytosis, βA4-protein deposition and paired helical filament formation in Alzheimer's disease. Journal of the Neurological Sciences 112 (1992), 68–75.
17. Callahan, L.M., Coleman, P.D., Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiology of Aging 16 (1995), 311–314.
18. Chen, K.D., Chang, P.T., Ping, Y.H., Lee, H.C., Yeh, C.W., Wang, P.N., Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease. Neurobiology of Disease 43 (2011), 698–705.
19. Ciccarelli, R., Di Iorio, P., Bruno, V., Battaglia, G., D'Alimonte, I., D'Onofrio, M., et al. Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100 protein from cultured astrocytes. GLIA 27 (1999), 275–281.
20. Cichocki, M., Blumczyńska, J., Baer-Dubowska, W., Naturally occurring phenolic acids inhibit 12-O-tetradecanoylphorbol-13-acetate induced NF-kappaB, iNOS and COX-2 activation in mouse epidermis. Toxicology 268 (2010), 118–124.
21. Clarke, R.E., Dordevic, A.L., Tan, S.M., Ryan, L., Coughlan, M.T., Dietary advanced glycation end products and risk factors for chronic disease: A systematic review of randomised controlled trials. Nutrients, 8(3), 2016, 125, 10.3390/nu8030125.
22. Copple, I.M., Shelton, L.M., Walsh, J., Kratschmar, D.V., Lister, A., Odermatt, A., et al. Chemical tuning enhances both potency toward nrf2 and in vitro therapeutic index of triterpenoids. Toxicological Sciences 140 (2014), 462–469.
23. Cruz, J.C., Tseng, H.-C., Goldman, J.A., Shih, H., Tsai, L.-H., Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40 (2003), 471–483.
24. Dall'asta, M., Derlindati, E., Curella, V., Mena, P., Calani, L., Ray, S., et al. Effects of naringenin and its phase II metabolites on in vitro human macrophage gene expression. International Journal of Food Sciences and Nutrition 64 (2013), 843–849.
25. Darvesh, A.S., Carroll, R.T., Bishayee, A., Geldenhuys, W.J., Van der Schyf, C.J., Oxidative stress and Alzheimer's disease: Dietary polyphenols as potential therapeutic agents. Expert Review of Neurotherapeutics 10 (2010), 729–745.
26. de Souza, D.F., Leite, M.C., Quincozes-Santos, A., Nardin, P., Tortorelli, L.S., Rigo, M.M., et al. S100B secretion is stimulated by IL-1beta in glial cultures and hippocampal slices of rats: Likely involvement of MAPK pathway. Journal of Neuroimmunology 206 (2009), 52–57.
27. Del Rio, D., Rodriguez-Mateos, A., Spencer, J.P., Tognolini, M., Borges, G., Crozier, A., Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants & Redox Signaling 18 (2013), 1818–1892.
28. Déniz-Naranjo, M.C., Muñoz-Fernandez, C., Alemany-Rodríguez, M.J., Pérez-Vieitez, M.C., Aladro-Benito, Y., Irurita-Latasa, J., et al. Cytokine IL-1 beta but not IL-1 alpha promoter polymorphism is associated with Alzheimer disease in a population from the Canary islands, Spain. European Journal of Neurology 15 (2008), 1080–1084.
29. Deo, A.K., Borson, S., Link, J.M., Domino, K., Eary, J.F., Ke, B., et al. Activity of P-glycoprotein, a β-amyloid transporter at the blood-brain barrier, is compromised in patients with mild Alzheimer disease. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 55 (2014), 1106–1111.
30. DiPatre, P.L., Gelman, B.B., Microglial cell activation in aging and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus. Journal of Neuropathology and Experimental Neurology 56 (1997), 143–149.
31. Dong, Y., Benveniste, E.N., Immune function of astrocytes. Glia 36 (2001), 180–190.
32. Edwards, M.M., Robinson, S.R., TNF alpha affects the expression of GFAP and S100B: Implications for Alzheimer's disease. Journal of Neural Transmission 113 (2006), 1709–1715.
33. Elnaggar, Y.S., Etman, S.M., Abdelmonsif, D.A., Abdallah, O.Y., Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer's disease: Optimization, biological efficacy, and potential toxicity. Journal of Pharmaceutical Sciences 104:10 (2015), 3544–3556.
34. Fang, S.H., Hou, Y.C., Chang, W.C., Hsiu, S.L., Chao, P.D., Chiang, B.L., Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sciences 74 (2003), 743–756.
35. Farina, N., Isaac, M.G., Clark, A.R., Rusted, J., Tabet, N., Vitamin E for Alzheimer's dementia and mild cognitive impairment. The Cochrane Database of Systematic Reviews, 11, 2012, CD002854, 10.1002/14651858.
36. Fehér, Á., Juhász, A., Pákáski, M., Kálmán, J., Janka, Z., ABCB1 C3435T polymorphism influences the risk for Alzheimer's disease. Journal of Molecular Neuroscience 54 (2014), 826–829.
37. Ferencik, M., Novak, M., Rovensky, J., Rybar, I., Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs. Bratislavské Lekárske Listy 102:3 (2001), 123–132.
38. Floyd, R.A., Hensley, K., Nitrone inhibition of age-associated oxidative damage. Annals of the New York Academy of Sciences 899 (2000), 222–237.
39. Ge, Y.-W., Lahiri, D.K., Regulation of promoter activity of the APP gene by cytokines and growth factors. Annals of the New York Academy of Sciences 973 (2002), 463–467.
40. Gerlach, R., Demel, G., König, H.G., Gross, U., Prehn, J.H.M., Raabe, A., et al. Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 141 (2006), 1697–1701.
41. Griffin, W.S.T., Liu, L., Li, Y., Mrak, R.E., Barger, S.W., Interleukin-1 mediates Alzheimer and Lewy body pathologies. Journal of Neuroinflammation, 3(1), 2006, 5.
42. Gubandru, M., Margina, D., Tsitsimpikou, C., Goutzourelas, N., Tsarouhas, K., Ilie, M., et al. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers. Food and Chemical Toxicology 61 (2013), 209–214.
43. Guglielmotto, M., Giliberto, L., Tamagno, E., Tabaton, M., Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. Frontiers in Aging Neuroscience, 2, 2010, 3.
44. Haass, C., Selkoe, D.J., Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75:6 (1993), 1039–1042.
45. Han, K.H., Hashimoto, N., Fukushima, M., Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes. World Journal of Gastroenterology 22 (2016), 37–49.
46. He, F.Q., Qiu, B.Y., Li, T.K., Xie, Q., Cui, D.J., Huang, X.L., et al. Tetrandrine suppresses amyloid-β-induced inflammatory cytokines by inhibiting NF-κB pathway in murine BV2 microglial cells. International Immunopharmacology 11 (2011), 1220–1225.
47. He, F.Q., Qiu, B.Y., Zhang, X.H., Li, T.K., Xie, Q., Cui, D.J., et al. Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer's disease induced by amyloid-β(1-42). Brain Research 1384 (2011), 89–96.
48. Head, E., Murphey, H.L., Dowling, A.L., McCarty, K.L., Bethel, S.R., Nitz, J.A., et al. A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease. Journal of Alzheimer's Disease 32:4 (2012), 1029–1042, 10.3233/JAD-2012-120937.
49. Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A., Evans, D.A., Alzheimer disease in the US population. Archives of Neurology 60 (2003), 1119–1122.
50. Heo, J.H., Hyon-Lee, Lee, K.M., The possible role of antioxidant vitamin C in Alzheimer's disease treatment and prevention. American Journal of Alzheimer's Disease and Other Dementias 28 (2013), 120–125.
51. Ho, L., Pasinetti, G.M., Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding. Expert Review of Proteomics 7 (2010), 579–589.
52. Hong, Z.Y., Shi, X.R., Zhu, K., Wu, T.T., Zhu, Y.Z., SCM-198 inhibits microglial overactivation and attenuates Aβ(1-40)-induced cognitive impairments in rats via JNK and NF-кB pathways. Journal of Neuroinflammation, 11, 2014, 147, 10.1186/s12974-014-0147-x.
53. Hosseini, B., Saedisomeolia, A., Wood, L.G., Yaseri, M., Tavasoli, S., Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: A randomized controlled clinical trial. Complementary Therapies in Clinical Practice 22 (2016), 44–50.
54. Hsu, S.P., Wu, M.S., Yang, C.C., Huang, K.C., Liou, S.Y., Hsu, S.M., et al. Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. American Journal of Clinical Nutrition 86 (2007), 1539–1547.
55. Hu, R., Saw, C.L., Yu, R., Kong, A.N., Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: Antioxidant coupled with antiinflammatory. Antioxidants & Redox Signaling 13 (2010), 1679–1698.
56. Ishii, T., Ishikawa, M., Miyoshi, N., Yasunaga, M., Akagawa, M., Uchida, K., et al. Catechol type polyphenol is a potential modifier of protein sulfhydryls: Development and application of a new probe for understanding the dietary polyphenol actions. Chemical Research in Toxicology 22 (2009), 1689–1698.
57. Jain, S., Rathod, V., Prajapati, R., Nandekar, P.P., Sangamwar, A.T., Pregnane X receptor and P-glycoprotein: A connexion for Alzheimer's disease management. Molecular Diversity 18 (2014), 895–909.
58. Jesse, S., Steinacker, P., Cepek, L., von Arnim, C.A., Tumani, H., Lehnert, S., et al. Glial fibrillary acidic protein and protein S-100B: Different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease. Journal of Alzheimer's Disease 17 (2009), 541–551.
59. Jia, L., Liu, J., Song, Z., Pan, X., Chen, L., Cui, X., et al. Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways. Journal of Pharmacy and Pharmacology 64 (2012), 1510–1521.
60. Kahlson, M.A., Colodner, K.J., Glial Tau pathology in tauopathies: Functional consequences. Journal of Experimental Neuroscience 9:Suppl. 2 (2015), 43–50.
61. Kamphuis, W., Mamber, C., Moeton, M., Kooijman, L., Sluijs, J.A., Jansen, A.H.P., et al. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PloS One, 7(8), 2012, e42823.
62. Kashon, M.L., Ross, G.W., O'Callaghan, J.P., Miller, D.B., Petrovitch, H., Burchfiel, C.M., et al. Associations of cortical astrogliosis with cognitive performance and dementia status. Journal of Alzheimer's Disease 6 (2004), 595–604.
63. Kawaguchi, Y., IL-lα gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clinical & Experimental Immunology 97 (2008), 445–450.
64. Kellow, N.J., Coughlan, M.T., Effect of diet-derived advanced glycation end products on inflammation. Nutrition Reviews 73 (2015), 737–759.
65. Khangholi, S., Majid, F.A., Berwary, N.J., Ahmad, F., Aziz, R.B., The mechanisms of inhibition of advanced glycation End products formation through polyphenols in hyperglycemic condition. Planta Medica 82 (2016), 32–45.
66. Krikorian, R., Boespflug, E.L., Fleck, D.E., Stein, A.L., Wightman, J.D., Shidler, M.D., et al. Concord grape juice supplementation and neurocognitive function in human aging. Journal of Agricultural and Food Chemistry 60 (2012), 5736–5742.
67. Krikorian, R., Shidler, M.D., Nash, T.A., Kalt, W., Vinqvist-Tymchuk, M.R., Shukitt-Hale, B., et al. Blueberry supplementation improves memory in older adults. Journal of Agricultural and Food Chemistry 58 (2010), 3996–4000.
68. Kuhnke, D., Jedlitschky, G., Grube, M., Krohn, M., Jucker, M., Mosyagin, I., et al. MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides—Implications for the mechanisms of abeta clearance at the blood-brain barrier. Brain Pathology 17 (2007), 347–353.
69. La Fata, G., Weber, P., Mohajeri, M.H., Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease. Nutrients 6 (2014), 5453–5472.
70. Leclerc, E., Heizmann, C.W., The importance of Ca2 +/Zn2 + signaling S100 proteins and RAGE in translational medicine. Frontiers in Bioscience (Scholar Edition) 3 (2011), 1232–1262.
71. Lee, S.C., Liu, W., Dickson, D.W., Brosnan, C.F., Berman, J.W., Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. Journal of Immunology 150 (1993), 2659–2667.
72. Li, Y., Liu, L., Barger, S.W., Griffin, W.S.T., Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. Journal of Neuroscience 23 (2003), 1605–1611.
73. Li, C., Zhao, R., Gao, K., Astrocytes: Implications for neuroinflammatory pathogenesis of Alzheimer's disease. Current Alzheimer Research 8 (2011), 67–80.
74. Liu, L., Chan, C., The role of inflammasome in Alzheimer's disease. Ageing Research Reviews 15 (2014), 6–15.
75. Liu, Z.J., Li, Z.H., Liu, L., Tang, W.X., Wang, Y., Dong, M.R., et al. Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer's disease. Frontiers in Pharmacology, 7, 2016, 261.
76. Liu, L., Martin, R., Chan, C., Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases. Neurobiology of Aging 34 (2013), 540–550.
77. López, N.J., Jara, L., Valenzuela, C.Y., Association of interleukin-1 polymorphisms with periodontal disease. The Journal of Periodontology 76 (2005), 234–243.
78. Maczurek, A., Shanmugam, K., Münch, G., Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Annals of the New York Academy of Sciences 1126 (2008), 147–151.
79. Mandrekar-Colucci, S., Landreth, G.E., Microglia and inflammation in Alzheimer's disease. CNS & Neurological Disorders Drug Targets 9 (2010), 156–167.
80. Markovits, N., Ben Amotz, A., Levy, Y., The effect of tomato-derived lycopene on low carotenoids and enhanced systemic inflammation and oxidation in severe obesity. The Israel Medical Association Journal 11 (2009), 598–601.
81. Matias, I., Buosi, A.S., Gomes, F.C., Functions of flavonoids in the central nervous system: Astrocytes as targets for natural compounds. Neurochemistry International 95 (2016), 85–91.
82. Medeiros, R., LaFerla, F.M., Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony. Experimental Neurology 239 (2013), 133–138.
83. Merfort, I., Heilmann, J., Weiss, M., Pietta, P., Gardana, C., Radical scavenger activity of three flavonoid metabolites studied by inhibition of chemiluminescence in human PMNs. Planta Medica 62 (1996), 289–292.
84. Mollenhauer, B., Bibl, M., Trenkwalder, C., Stiens, G., Cepek, L., Steinacker, P., et al. Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease. Journal of Neural Transmission 112 (2005), 933–948.
85. Monagas, M., Khan, N., Andrés-Lacueva, C., Urpí-Sardá, M., Vázquez-Agell, M., Lamuela-Raventós, R.M., et al. Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. British Journal of Nutrition 102 (2009), 201–206.
86. Monnier, V., Cerami, A., Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science 211 (1981), 491–493.
87. Moosavi, F., Hosseini, R., Saso, L., Firuzi, O., Modulation of neurotrophic signaling pathways by polyphenols. Drug Design, Development and Therapy 10 (2016), 23–42.
88. Moslemnezhad, A., Mahjoub, S., Moghadasi, M., Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease. Caspian Journal of Internal Medicine 7 (2016), 88–92.
89. Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R.A., Aisen, P.S., et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. Journal of Neuroinflammation, 14, 2017, 1.
90. Mrak, R.E., Griffin, W.S.T., Glia and their cytokines in progression of neurodegeneration. Neurobiology of Aging 26 (2005), 349–354.
91. Nada, S.E., Shah, Z.A., Preconditioning with Ginkgo biloba (EGb 761®) provides neuroprotection through HO1 and CRMP2. Neurobiology of Disease 46 (2012), 180–189.
92. Nagele, R., Wegiel, J., Venkataraman, V., Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiology of Aging 25 (2004), 663–674.
93. Nair, S., Li, W., Kong, A.N., Natural dietary anti-cancer chemopreventive compounds: Redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta Pharmacologica Sinica 28 (2007), 459–472.
94. Nestor, P.J., Scheltens, P., Hodges, J., Advances in the early detection of Alzheimer's disease. Nature Medicine 12 (2006), s34–s41.
95. Nieman, D.C., Cialdella-Kam, L., Knab, A.M., Shanely, R.A., Influence of red pepper spice and turmeric on inflammation and oxidative stress biomarkers in overweight females: A metabolomics approach. Plant Foods for Human Nutrition 67 (2012), 415–421.
96. Notturno, F., Capasso, M., DeLauretis, A., Carpo, M., Uncini, A., Glial fibrillary acidic protein as a marker of axonal damage in chronic neuropathies. Muscle & Nerve 40 (2009), 50–54.
97. Onyango, I.G., Tuttle, J.B., Bennett, J.P., Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE). Molecular and Cellular Neurosciences 29 (2005), 333–343.
98. Pahnke, J., Langer, O., Krohn, M., Alzheimer's and ABC transporters—New opportunities for diagnostics and treatment. Neurobiology of Disease 72 Pt. A (2014), 54–60.
99. Palimeri, S., Palioura, E., Diamanti-Kandarakis, E., Current perspectives on the health risks associated with the consumption of advanced glycation end products: Recommendations for dietary management. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 8 (2015), 415–426.
100. Park, W.H., Kang, S., Piao, Y., Pak, C.J., Oh, M.S., Kim, J., et al. Ethanol extract of bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB. Journal of Ethnopharmacology 174 (2015), 37–44.
101. Parpura, V., Haydon, P.G., (eds.) Astrocytes in (Patho)Physiology of the Nervous System, 2009, Springer US, Boston, MA http://doi.org/10.1007/978-0-387-79492-1.
102. Pelinka, L.E., Kroepfl, A., Leixnering, M., Buchinger, W., Raabe, A., Redl, H., GFAP versus S100B in serum after traumatic brain injury: Relationship to brain damage and outcome. Journal of Neurotrauma 21 (2004), 1553–1561.
103. Peluso, I., Palmery, M., Flavonoids at the pharma-nutrition interface: Is a therapeutic index in demand?. Biomedicine & Pharmacotherapy 71 (2015), 102–107.
104. Pena, L.A., Brecher, C.W., Marshak, D.R., beta-Amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures. Brain Research. Molecular Brain Research 34 (1995), 118–126.
105. Peppa, M., Uribarri, J., Vlassara, H., Aging and glycoxidant stress. Hormones 7 (2008), 123–132.
106. Persson, T., Popescu, B.O., Cedazo-Minguez, A., Oxidative stress in Alzheimer's disease: Why did antioxidant therapy fail?. Oxidative Medicine and Cellular Longevity, 2014, 2014, 11, 10.1155/2014/427318 Article ID 427318.
107. Ries, M., Sastre, M., Mechanisms of Aβ clearance and degradation by glial cells. Frontiers in Aging Neuroscience, 8, 2016, 160.
108. Rogers, J., Webster, S., Lue, L.-F., Brachova, L., Harold Civin, W., Emmerling, M., et al. Inflammation and Alzheimer's disease pathogenesis. Neurobiology of Aging 17 (1996), 681–686.
109. Rossner, S., Lange-Dohna, C., Alzheimer's disease β secretase BACE1 is not a neuron specific enzyme. Journal of Neurochemistry 92 (2005), 226–234.
110. Rubio-Perez, J.M., Albaladejo, M.D., Zafrilla, P., Vidal-Guevara, M.L., Morillas-Ruiz, J.M., Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patients. European Journal of Nutrition 55 (2016), 2105–2116.
111. Rubio-Perez, J.M., Morillas-Ruiz, J.M., Serum cytokine profile in Alzheimer's disease patients after ingestion of an antioxidant beverage. CNS & Neurological Disorders Drug Targets 12 (2013), 1233–1241.
112. Saido, T., Metabolism and Alzheimer's disease. Proceedings of the Japan Academy. Series B Physical and Biological Sciences 7 (2003), 321–339.
113. Samadi, A.K., Bilsland, A., Georgakilas, A.G., Amedei, A., Amin, A., Bishayee, A., et al. A multi-targeted approach to suppress tumor-promoting inflammation. Seminars in Cancer Biology 35 (2015), S151–S184.
114. Sasaki, S., Tozawa, T., Sugamoto, K., Matsushita, Y., Satoh, T., A novel di terpene para-hydroquinone compound derived from cryptoquinone protects neuronal cells against oxidative stress and activates the Nrf2/ARE pathway. Neuroscience Letters 548 (2013), 132–136.
115. Sathe, K., Maetzler, W., Lang, J.D., Mounsey, R.B., Fleckenstein, C., Martin, H.L., et al. S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway. Brain 135 (2012), 3336–3347.
116. Schmidt, B., Braun, H.A., Narlawar, R., Drug development and PET-diagnostics for Alzheimer's disease. Current Medicinal Chemistry 12 (2005), 1677–1695.
117. Schrag, M., Mueller, C., Zabel, M., Crofton, A., Kirsch, W.M., Ghribi, O., et al. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis. Neurobiology of Disease 59 (2013), 100–110.
118. Sedaghat, F., Notopoulos, A., S100 protein family and its application in clinical practice. Hippokratia 12 (2008), 198–204.
119. Selkoe, D.J., Defining molecular targets to prevent Alzheimer disease. Archives of Neurology 62 (2005), 192–195.
120. Semba, R.D., Nicklett, E.J., Ferrucci, L., Does accumulation of advanced glycation end products contribute to the aging phenotype?. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 65 (2010), 963–975.
121. Seneff, S., Wainwright, G., Mascitelli, L., Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate diet. European Journal of Internal Medicine 22 (2011), 134–140.
122. Sheng, J.G., Jones, R.A., Zhou, X.Q., McGinness, J.M., Van Eldik, L.J., Mrak, R.E., et al. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: Potential significance for tau protein phosphorylation. Neurochemistry International 39 (2001), 341–348.
123. Sheng, J.G., Mrak, R.E., Griffin, W.S., Glial-neuronal interactions in Alzheimer disease: Progressive association of IL-1alpha + microglia and S100beta + astrocytes with neurofibrillary tangle stages. Journal of Neuropathology and Experimental Neurology 56 (1997), 285–290.
124. Sidoryk-Wegrzynowicz, M., Aschner, M., Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacology & Toxicology, 14, 2013, 23.
125. Sidoryk-Wegrzynowicz, M., Wegrzynowicz, M., Lee, E., Bowman, A.B., Aschner, M., Role of astrocytes in brain function and disease. Toxicologic Pathology 39 (2011), 115–123.
126. Simpson, J.E., Ince, P.G., Lace, G., Forster, G., Shaw, P.J., Matthews, F., et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiology of Aging 31 (2010), 578–590.
127. Singhal, G., Jaehne, E.J., Corrigan, F., Toben, C., Baune, B.T., Inflammasomes in neuroinflammation and changes in brain function: A focused review. Frontiers in Neuroscience 8 (2014), 1–22.
128. Sirota, R., Gibson, D., Kohen, R., The role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines. Redox Biology 4 (2015), 48–59.
129. Sofroniew, M.V., Molecular dissection of reactive astrogliosis and glial scar formation. Trends in Neurosciences 32 (2009), 638–647.
130. Solfrizzi, V., Panza, F., Plant-based nutraceutical interventions against cognitive impairment and dementia: Meta-analytic evidence of efficacy of a standardized Gingko biloba extract. Journal of Alzheimers Disease 43 (2015), 605–611.
131. Solito, E., Sastre, M., Microglia function in Alzheimer's disease. Frontiers in Pharmacology, 3, 2012, 14, 10.3389/fphar.2012.00014.
132. Son, P.S., Park, S.A., Na, H.K., Jue, D.M., Kim, S., Surh, Y.J., Piceatannol, a catechol-type polyphenol, inhibits phorbol ester-induced NF-{kappa}B activation and cyclooxygenase-2 expression in human breast epithelial cells: Cysteine 179 of IKK{beta} as a potential target. Carcinogenesis 31 (2010), 1442–1449.
133. Spencer, J.P., Vafeiadou, K., Williams, R.J., Vauzour, D., Neuroinflammation: Modulation by flavonoids and mechanisms of action. Molecular Aspects of Medicine 33 (2012), 83–97.
134. Srivastava, S., Saksena, A.K., Khattri, S., Kumar, S., Dagur, R.S., Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: A four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology 24 (2016), 377–388.
135. Streit, W.J., Microglial senescence: Does the brain's immune system have an expiration date?. Trends in Neurosciences 29 (2006), 506–510.
136. Suri, S., Taylor, M.A., Verity, A., Tribolo, S., Needs, P.W., Kroon, P.A., et al. A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochemical Pharmacology 76 (2008), 645–653.
137. Takeda, S., Sato, N., Morishita, R., Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: Relevance to pathogenesis and therapy. Frontiers in Aging Neuroscience, 6, 2014, 171.
138. Thangthaeng, N., Poulose, S.M., Miller, M.G., Shukitt-Hale, B., Preserving brain function in aging: The anti-glycative potential of berry fruit. Neuromolecular Medicine 18 (2016), 465–473.
139. Tiwari, S.K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway. ACS Nano 8:1 (2014), 76–103, 10.1021/nn405077y.
140. Uribarri, J., del Castillo, M.D., de la Maza, M.P., Filip, R., Gugliucci, A., Luevano-Contreras, C., et al. Dietary advanced glycation end products and their role in health and disease. Advances in Nutrition 6 (2015), 461–473.
141. van Assema, D.M., Lubberink, M., Bauer, M., van der Flier, W.M., Schuit, R.C., Windhorst, A.D., et al. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain 135 (2012), 181–189.
142. van Assema, D.M., Lubberink, M., Rizzu, P., van Swieten, J.C., Schuit, R.C., Eriksson, J., et al. Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: Effect of polymorphisms in the ABCB1 gene. EJNMMI Research, 2(1), 2012, 57, 10.1186/2191-219X-2-57.
143. Van Eldik, L.J., Zimmer, D.B., Secretion of S-100 from rat C6 glioma cells. Brain Research 436 (1987), 367–370.
144. Van Puyvelde, K., Mets, T., Njemini, R., Beyer, I., Bautmans, I., Effect of advanced glycation end product intake on inflammation and aging: A systematic review. Nutrition Reviews 72 (2014), 638–650.
145. Veerhuis, R., Histological and direct evidence for the role of complement in the neuroinflammation of AD. Current Alzheimer Research 8 (2011), 34–58.
146. Venigalla, M., Sonego, S., Gyengesi, E., Sharman, M.J., Münch, G., Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease. Neurochemistry International 95 (2016), 63–74.
147. Vesce, S., Rossi, D., Brambilla, L., Volterra, A., Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. International Review of Neurobiology 82 (2007), 57–71.
148. Walsh, D.M., Selkoe, D.J., Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004), 181–193.
149. Wang, L., Gao, S., Jiang, W., Luo, C., Xu, M., Bohlin, L., et al. Antioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migration. International Journal of Molecular Sciences 15 (2014), 16226–16245.
150. Wang, W., Shinto, L., Connor, W.E., Quinn, J.F., Nutritional biomarkers in Alzheimer's disease: The association between carotenoids, n-3 fatty acids, and dementia severity. Journal of Alzheimers Disease 13 (2008), 31–38.
151. Webster, B., Hansen, L., Adame, A., Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. Journal of Neuropathology & Experimental Neurology 65 (2006), 142–151.
152. Weiner, H.L., Frenkel, D., Immunology and immunotherapy of Alzheimer's disease. Nature Reviews. Immunology 6 (2006), 404–416.
153. Williams, R.J., Spencer, J.P., Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radical Biology and Medicine 52 (2012), 35–45.
154. Wood, L.G., Garg, M.L., Smart, J.M., Scott, H.A., Barker, D., Gibson, P.G., Manipulating antioxidant intake in asthma: A randomized controlled trial. American Journal of Clinical Nutrition 96 (2012), 534–543.
155. Wu, P.T., Fitschen, P.J., Kistler, B.M., Jeong, J.H., Chung, H.R., Aviram, M., et al. Effects of pomegranate extract supplementation on cardiovascular risk factors and physical function in hemodialysis patients. Journal of Medicinal Food 18 (2015), 941–949.
156. Wu, R.P., Hayashi, T., Cottam, H.B., Jin, G., Yao, S., Wu, C.C., et al. Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 107 (2010), 7479–7484.
157. Wyss-Coray, T., Inflammation in Alzheimer disease: Driving force, bystander or beneficial response?. Nature Medicine 12 (2006), 1005–1015.
158. Wyss-Coray, T., Loike, J.D., Brionne, T.C., Lu, E., Anankov, R., Yan, F., et al. Adult mouse astrocytes degrade amyloid-β in vitro and in situ. Nature Medicine 9:4 (2003), 453–457.
159. Wyss-Coray, T., Rogers, J., Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harbor Perspectives in Medicine, 2(1), 2012, a006346.
160. Yan, L., Xiao, M., Chen, R., Cai, Z., Metabolic dysfunction of astrocyte: An initiating factor in beta-amyloid pathology?. Aging and Neurodegeneration 1 (2013), 7–14.
161. Yang, Q., Hamberger, A., Hyden, H., Wang, S., Stigbrand, T., Haglid, K.G., S-100β has a neuronal localisation in the rat hindbrain revealed by an antigen retrieval method. Brain Research 696 (1995), 49–61.
162. Yarla, N.S., Bishayee, A., Sethi, G., Reddanna, P., Kalle, A.M., Dhananjaya, B.L., et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Seminars in Cancer Biology 40–41 (2016), 48–81.
163. Yu, X., Wang, L.N., Du, Q.M., Ma, L., Chen, L., You, R., et al. Akebia Saponin D attenuates amyloid β-induced cognitive deficits and inflammatory response in rats: Involvement of Akt/NF-κB pathway. Behavioural Brain Research 235 (2012), 200–209.
164. Yuan, L., Liu, J., Ma, W., Dong, L., Wang, W., Che, R., et al. Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China. Nutrition 32 (2016), 193–198.
165. Yucesoy, B., Peila, R., White, L.R., Wu, K.M., Johnson, V.J., Kashon, M.L., et al. Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: The Honolulu-Asia aging study. Neurobiology of Aging 27 (2006), 211–217.
166. Zern, T.L., Wood, R.J., Greene, C., West, K.L., Liu, Y., Aggarwal, D., et al. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. Journal of Nutrition 135 (2005), 1911–1917.
167. Zhao, H.F., Li, N., Wang, Q., Cheng, X.J., Li, X.M., Liu, T.T., Resveratrol decreases the insoluble Aβ1-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience 310 (2015), 641–649.
168. Zilka, N., Ferencik, M., Hulin, I., Neuroinflammation in Alzheimer's disease: Protector or promoter?. Bratislavské Lekárske Listy 107 (2006), 374–383.